Labcorp Holdings Inc. LH

Healthcare · Diagnostics & Research · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$9.74B
Market Cap
$24.73B
Margin of Safety
-154.0%
Intrinsic / Market Ratio
0.39

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

11.16B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

9.71B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

8.34B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

9.74B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

9.74B USD

from the sum above

Market Cap

24.73B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.39×

the ratio the screener ranks by; Margin of Safety -154.0% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 11.16B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)14.33B USD
−②Net Debt Today6.63B USD
+③Growth Value3.46B USD
=Value11.16B USD

EPV of the Operations (NOPAT over WACC)

14.33B USD

Net debt today

-6.63B USD

Growth Value

+3.46B USD

Value

11.16B USD

①EPV (earnings power value)

14.33B USD

②Net Debt Today

6.63B USD

③Growth Value

3.46B USD

Market value

Market Cap24.73B USD

Today's price times the shares.

Value vs market

Margin of Safety-121.6%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 9.71B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE7.08B USD
+②Equity at Year 15, Today2.63B USD
=Value9.71B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROE on new investment rising to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

7.08B USD

②Equity at Year 15, Today

2.63B USD

Market value

Market Cap24.73B USD

Today's price times the shares.

Value vs market

Margin of Safety-154.8%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 8.34B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF8.82B USD
+②Invested Capital at Year 15, Today6.15B USD
−③Net Debt Today6.63B USD
=Value8.34B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment rising to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

8.82B USD

②Invested Capital at Year 15, Today

6.15B USD

③Net Debt Today

6.63B USD

Market value

Market Cap24.73B USD

Today's price times the shares.

Value vs market

Margin of Safety-196.4%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 8.11%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.85×Market Risk Premium 6.00%= 9.61%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 230.03M USDPretax Income 1.11B USD= 20.75%

The tax the interest saves.

Interest Expense =EBIT 1.33B USD−Pretax Income 1.11B USD= 224.32M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 224.32M USDTotal Debt 6.77B USD×(1 − Tax Rate for WACC 20.75%)= 2.62%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 6.77B USDMarket Cap + Total Debt 24.73B USD + 6.77B USD= 21.50%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 78.50%×Cost of Equity 9.61%+Debt Weight 21.50%×Cost of Debt 2.62%= 8.11%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 18.55B USD − Total Liabilities 9.92B USD = Book Value Today 8.63B USD

Total Debt 6.77B USD − Cash and Short-Term Investments 141.94M USD = Net Debt Today 6.63B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-3.6%at most 5%passes80,900,000 / 83,900,000
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets4.1%at least -10.0%passes(1.64B USD − 877.38M USD) ÷ 18.55B USD
Price to bookMarket Cap ÷ Book Value Today2.86×at most 3×passes24.73B USD ÷ 8.63B USD
Operating marginOperating Income ÷ Revenue10.9%above 10.0%passes1.52B USD ÷ 13.97B USD
Revenue growthRevenue ÷ Revenue a Year Before − 17.2%above 10.0%does not pass13.97B USD / 13.02B USD
Net cash(Cash − Total Debt) ÷ Market Cap-26.8%above -30%passes(141.94M USD − 6.77B USD) ÷ 24.73B USD
Operating efficiencyOperating Income ÷ Gross Profit37.8%above 25.0%passes1.52B USD ÷ 4.02B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

305 USD

Enterprise value

31.43B USD

market cap plus net debt

EV / EBITDA

13.54×

Price / book

2.86×

the provider's book

Price / earnings

25.22×

Return on equity

11.7%

the provider's, not the engine's

Profit margin

7.0%

Revenue growth

5.8%

Analyst target, mean

345 USD

Analysts

16

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

11.88B12.17B13.02B13.97B

Gross profit

3.71B3.37B3.63B4.02B

Operating income

1.75B1.12B1.14B1.52B

EBITDA

operating income before depreciation and amortisation

1.96B1.35B1.81B2.01B

Pretax income

1.24B569.47M960.46M1.11B

Net income

1.28B418.42M746.75M877.38M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

1.25B626.89M769.36M969.69M

R&D

————
Balance sheet, year end

Total assets

20.18B16.74B18.40B18.41B

Total liabilities

10.05B8.84B10.32B9.77B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

10.11B7.88B8.06B8.63B

Total debt

6.25B5.96B7.28B6.53B

Cash and equivalents

320.92M537.34M1.52B532.83M

Net PP&E

fixed assets after depreciation

2.80B2.91B3.05B3.08B

Working capital

current assets less current liabilities

1.55B540.74M1.48B1.20B
Cash flow

Operating cash flow

1.96B1.33B1.59B1.64B

Capital expenditure

paid out, so below zero

-429.73M-454.05M-490.39M-434.93M

Depreciation and amortisation

537.74M577.88M644.14M681.78M

Free cash flow

operating cash flow plus capital expenditure

1.53B874.97M1.10B1.21B